NCT07562542
- Conditions
- Immune System Diseases, KIT-D816V Mutation, Mast Cell Activation Disorders, +7 more
- Locations
-
- The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, Jiangsu, China
Clinical trial condition
Systemic Mastocytosis
Explore clinical trials studying Systemic Mastocytosis. Study availability and eligibility vary by location and protocol.
13 public trials
2 recruiting studies
Systemic Mastocytosis trial results
Recruiting
Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
NCT07142473
- Conditions
- Cutaneous Mastocytosis, Immune System Diseases, Mast Cell Activation Disorders, +12 more
- Locations
-
- SC Dermatologia, Fondazione IRCCS Policlinico San Matteo Pavia, Italy
NCT00449748
- Conditions
- Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +6 more
- Locations
-
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
NCT03401060
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Immune System Diseases, +12 more
- Locations
-
- Jean Minjoz Hospital, Dermatology department Besançon, France
- Caen Hospital, Clinical haematology department Caen, France
- Estaing Hospital, Cellular therapy and clinical haematology department Clermont-Ferrand, France
- Lille CHRU Hospital, Internal medicine and clinical immunology department Lille, France
NCT04681105
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT00109707
- Conditions
- Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +27 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford University Medical Center Stanford, California, United States
- University of Colorado Hospital Aurora, Colorado, United States
- H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt Tampa, Florida, United States
NCT01334996
- Conditions
- Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +6 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT02441166
- Conditions
- Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +11 more
- Locations
-
- CHU Bordeaux Hôpital Haut-Lévêque, service de dermatologie Bordeaux, France
- CHU de Caen, service d'hématologie Caen, France
- CHU Dupuytren service d'hématologie Limoges, France
- CHU Lyon Sud, service de médecine interne Lyon, France
Completed
Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
NCT01807598
- Conditions
- Aggressive Systemic Mastocytosis, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00171912
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +32 more
- Locations
-
- Novartis Investigative Site East Melbourne, Australia